Rho(D) Immune Globulin (Human)

抗D免疫球蛋白（Kedrion）

Report date: 2024/08/23 17:29:46

Base Information

Drug NameRho(D) Immune Globulin (Human)
Drug Alias NameRHO immuneRho(D)免疫球蛋白(人)抗RHD免疫球蛋白Rho(D) immune globulin抗D免疫球蛋白（强生） +[10] 
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors
TargetsBlood group Rh(D) polypeptide
Therapy Area/IndicationsHematologic DiseasesFetal Diseases
Global Approved IndicationsHematologic DiseasesFetal Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1968/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKedrion Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKedrion Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHematologic DiseasesFetal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A